AGENUS INC Adjustments to Additional Paid in Capital, Warrant Issued
AGENUS INC (AGEN) reported Adjustments to Additional Paid in Capital, Warrant Issued of $3.15 million for the 12-month period ending 2020-12-31, per its 10-K filed 2023-03-16.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2023-03-16
- AGENUS INC adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $3.15M.
- AGENUS INC adjustments to additional paid in capital, warrant issued for fiscal 2020 was $3.15M.
- AGENUS INC adjustments to additional paid in capital, warrant issued for fiscal 2015 was $3.04M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2020-12-31 | $3.15M 10-K · filed 2023-03-16 | |
| 2020-03-31 | $3.15M 10-Q · filed 2021-11-09 | |
| 2015-12-31 | $3.04M 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |